ClinicalTrials.gg
Not yet recruitingNCT06389604Prep4heatUpdated Apr 29, 2024

Preparing for Heat Waves - Enhancing Human Thermophysiological Resilience

An interventional study of Heat acclimation in Body Temperature Changes, Heat Exposure and Heat Stress, sponsored by Maastricht University Medical Center. Not yet recruiting. Open to participants aged 60 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-29.

Primary conditionHyperthermiaRegistry: Body Temperature ChangesReclassifiedWhy we changed it
Registry
Body Temperature Changes — the first condition term the registry derived for this study.
ClinicalTrials.gg
Hyperthermia
Why
  1. The study's listed conditions name Hyperthermia, a narrower term within Body Temperature Changes.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Maastricht University Medical Center · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
60 Years to 80 Years
Sex
All
01

Study summary

As the ongoing progression of climate change exposes individuals to elevated temperatures and an escalating frequency of extreme heat events, the risk of more intense and prolonged heat waves raises significant concerns for public health, particularly among vulnerable populations. The physiological response to acute heat stress involves involuntary thermolytic reactions that may strain the cardiovascular system, especially in individuals with pre-existing vulnerabilities. Heat acclimation has been identified as a potential strategy to enhance thermoregulation and mitigate the adverse effects of heat stress. While existing research primarily focuses on athletes and military, this study aims to investigate the impact of a practical heat acclimation strategy, combining passive and active heat exposure, on thermophysiological, cardiovascular and metabolic parameters in healthy overweight adults. The study targets a population at increased risk for heat-related complications, seeking to provide realistic guidelines for broader application when a heat wave appears on the weather forecast.

Read the detailed description

A non-randomized, within-subject experimental trial will be conducted. The complete study will consist of a screening day, a control week, a heat acclimation week, 3 heat stress test (HST) and meal-test (MT) days (t = -7, 0, and 8 (days)). To avoid a confounding effect of seasonal thermal differences and achieve maximal methodological quality, the study will be performed in the shortest possible timeframe for each participant. Given the seasonal fluctuations in NL, transitioning from April (\~7oC) to June (\~20oC), a crossover design is not applicable as a washout period of approximately 2 months would be needed and the measurements would likely take place in different climatic outdoor conditions. In total, 12 healthy male and female participants will be included in the study. During the no-intervention week (week 1), participants will be asked to continue their normal life at home, without being present at the university. In addition, during week 1, participants will be asked to wear a temperature sensor on their clothing to measure the environment temperature they are exposed to at home. Thereafter, on the intervention week (week 2), participants will be exposed to increasing elevated temperatures and undergo 30 min of low-to-moderate intensity cycling in the heated laboratory room for 7 days. The temperature settings are derived from past heat waves in the Netherlands, ensuring a realistic representation. The low exercise intensity is selected to be accessible to the majority of individuals within the target population. The HST-MT will be conducted on the first visit after the screening to serve as baseline measurements. The same tests will also be repeated before and after the heat acclimation week to determine the physiological response to increasing ambient temperatures. All measurements will take place in the Metabolic Research Unit of Maastricht University (MRUM), the Netherlands.

02

Conditions studied

  • Body Temperature Changes
  • Heat Exposure
  • Heat Stress
  • Hyperthermia

Browse trials for

Keywords

  • heat acclimation
  • thermoregulation
  • heat exposure
  • cardiovascular
03

In context

Hyperthermia Reclassified

256 studies on the registry are indexed under Hyperthermia; 73 are open to participants now.

This study's planned enrollment of 12 is below the median of 40 across 232 interventional studies indexed under Hyperthermia.

Browse Hyperthermia studies →

Lead sponsor

Maastricht University Medical Center is the lead sponsor of 853 studies on the registry; 114 are open to participants now.

Compared within Hyperthermia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Body Temperature Changes. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
60 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy males and females
  • 60 to 80 years
  • 25-30 kg/m2
  • Sedentary (\<2h exercise/week)

Exclusion criteria

Exclusion Criteria:

  • Presence of chronic cardiovascular disease, as determined by medical history and physical examination
  • Participating in a structured exercise program
  • Taking hot baths/saunas regularly
  • Travelled for a prolonged time to destinations with elevated temperatures the last 3 months
  • Pre-existing T2DM
  • Blood donation within a month of study initiation
  • People with low concentration (males: Hb = 13.5-17.5 g/dL, females: Hb = 11.5-15.5 g/dL)
  • Recent participation in biomedical study (less than 1 month)
  • Using any medication that may influence glucose or lipid metabolism (beta-blockers, thyroid medications, stimulants, antidepressants, anticoagulants)
  • Smoking or abuse of alcohol
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (estimated)

Study arms

  • Experimental
    Heat acclimation

    Passive heat exposure (29-35ºC; 6h/day for 7 days) in combination with 30min/day low-to-moderate intensity cycling.

    Other: Heat acclimation

Interventions

  • OtherHeat acclimation

    Daily repeated heat exposure to assess the effects of combined passive and active heat acclimation

06

What researchers measure

Primary outcomes

  1. Core temperature

    thermophysiological parameters (ºC)

    Time frame: 1 week of heat acclimation

Secondary outcomes

  1. Skin temperature

    thermophysiological parameters (ºC)

    Time frame: 1 week of heat acclimation

  2. Sweat rate

    thermophysiological parameters (mL/min)

    Time frame: 1 week of heat acclimation

  3. Heart rate

    cardiovascular parameters (bpm)

    Time frame: 1 week of heat acclimation

  4. Blood pressure

    cardiovascular parameters (mmHg)

    Time frame: 1 week of heat acclimation

  5. Skin blood flow

    cardiovascular parameters (mL/min)

    Time frame: 1 week of heat acclimation

  6. Energy expenditure

    Metabolic parameters (kJ/min)

    Time frame: 1 week of heat acclimation

  7. Substrate oxidation

    glucose and fat oxidation (umol/kg/min)

    Time frame: 1 week of heat acclimation

  8. Plasma metabolites

    Plasma glucose, insulin, free-fatty acids, triglycerides, total cholesterol (mmol/L)

    Time frame: 1 week of heat acclimation

  9. Brain blood flow

    additional cardiovascular parameters (mL/min)

    Time frame: 1 week of heat acclimation

  10. Flow-mediated dilation

    endothelial function, (mm)

    Time frame: 1 week of heat acclimation

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Pallubinsky H, Schellen L, Kingma BRM, Dautzenberg B, van Baak MA, van Marken Lichtenbelt WD. Thermophysiological adaptations to passive mild heat acclimation. Temperature (Austin). 2017 Mar 10;4(2):176-186. doi: 10.1080/23328940.2017.1303562. eCollection 2017. Erratum In: Temperature (Austin). 2018 Apr 4;5(1):100. doi: 10.1080/23328940.2018.1448542. PubMed 28680933 ↗
  • Pallubinsky H, Phielix E, Dautzenberg B, Schaart G, Connell NJ, de Wit-Verheggen V, Havekes B, van Baak MA, Schrauwen P, van Marken Lichtenbelt WD. Passive exposure to heat improves glucose metabolism in overweight humans. Acta Physiol (Oxf). 2020 Aug;229(4):e13488. doi: 10.1111/apha.13488. Epub 2020 Jun 1. PubMed 32359193 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2024; primary completion for Dec 2024, 7 months later.

Of 103 non-industry interventional studies with no phase under Hyperthermia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 7 months is below that.

Counting every sponsor, half of 108 studies reached it within 18 months; a quarter within 7 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 5, 2024
First posted
Apr 29, 2024
StartEst.
May 2024
Primary completionEst.
Dec 2024
CompletionEst.
Dec 2024
Last update
Apr 29, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06389604
Responsible party
Sponsor
First posted
Apr 29, 2024
Start date
May 2024 (estimated)
Primary completion
Dec 2024 (estimated)
Completion
Dec 2024 (estimated)
Last update
Apr 29, 2024

Study contacts

Sofia Pappa, M.Sc.
Contact
sofia.pappa@maastrichtuniversity.nl
+31433882507
Hannah Pallubinsky, Dr.
principal investigator · Maastricht University
Guy Plasqui
principal investigator · Maastricht University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion